DB17623InvestigationalProtein Based Therapies
Clervonafusp alfa: Overview.
- Also known as
- Immunoglobulin g1-kappa, cell-penetrating humanized fab fragment targeting the equilibrative nucleoside transporter 2 (ent2), fused with a human lysosomal .alpha.-glucosidase fragment, glycoform alfa · Immunoglobulin g1, (humanized monoclonal 3e10 .gamma.1-chain fab fragment) fusion protein with 67-952-lysosomal .alpha.-glucosidase (human recombinant), disulfide with humanized monoclonal 3e10 .kappa.-chain
- Code names
- VAL-1221
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Clervonafusp alfa, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account